Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
GH Research PLC has a consensus price target of $35 based on the ratings of 9 analysts. The high is $66 issued by Roth Capital on June 16, 2022. The low is $14 issued by Cantor Fitzgerald on February 13, 2025. The 3 most-recent analyst ratings were released by Guggenheim, RBC Capital, and Stifel on March 13, 2025, March 7, 2025, and February 27, 2025, respectively. With an average price target of $31.67 between Guggenheim, RBC Capital, and Stifel, there's an implied 155.58% upside for GH Research PLC from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/13/2025 | Buy Now | 158.27% | Guggenheim | Eddie Hickman63% | → $32 | Initiates | → Buy | Get Alert |
03/07/2025 | Buy Now | 150.2% | RBC Capital | Brian Abrahams52% | → $31 | Initiates | → Outperform | Get Alert |
02/27/2025 | Buy Now | 158.27% | Stifel | Paul Matteis44% | $18 → $32 | Maintains | Buy | Get Alert |
02/13/2025 | Buy Now | 12.99% | Cantor Fitzgerald | Charles Duncan72% | → $14 | Initiates | → Overweight | Get Alert |
01/27/2025 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
01/13/2025 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
01/10/2025 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
11/20/2024 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
11/18/2024 | Buy Now | 125.99% | Canaccord Genuity | Sumant Kulkarni43% | $31 → $28 | Maintains | Buy | Get Alert |
09/05/2024 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
09/04/2024 | Buy Now | 214.77% | JMP Securities | Jason Butler56% | $39 → $39 | Reiterates | Market Outperform → Market Outperform | Get Alert |
07/31/2024 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
05/07/2024 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
05/06/2024 | Buy Now | 150.2% | Canaccord Genuity | Sumant Kulkarni43% | $30 → $31 | Maintains | Buy | Get Alert |
03/04/2024 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
03/01/2024 | Buy Now | 214.77% | JMP Securities | Jason Butler56% | $50 → $39 | Maintains | Market Outperform | Get Alert |
01/18/2024 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 222.84% | HC Wainwright & Co. | Patrick Trucchio47% | $45 → $40 | Maintains | Buy | Get Alert |
07/06/2023 | Buy Now | 263.2% | HC Wainwright & Co. | Patrick Trucchio47% | → $45 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 263.2% | HC Wainwright & Co. | Patrick Trucchio47% | → $45 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 295.48% | JMP Securities | Jason Butler56% | $46 → $49 | Maintains | Outperform | Get Alert |
03/13/2023 | Buy Now | 263.2% | HC Wainwright & Co. | Patrick Trucchio47% | → $45 | Reiterates | → Buy | Get Alert |
03/02/2023 | Buy Now | 166.34% | EF Hutton | Elemer Piros56% | → $33 | Reiterates | → Buy | Get Alert |
12/16/2022 | Buy Now | 166.34% | EF Hutton | Elemer Piros56% | → $33 | Initiates | → Buy | Get Alert |
08/16/2022 | Buy Now | 263.2% | HC Wainwright & Co. | Patrick Trucchio47% | → $45 | Initiates | → Buy | Get Alert |
06/16/2022 | Buy Now | 432.69% | Roth Capital | Elemer Piros56% | → $66 | Initiates | → Buy | Get Alert |
04/13/2022 | Buy Now | 230.91% | Canaccord Genuity | Sumant Kulkarni43% | $45 → $41 | Maintains | Buy | Get Alert |
The latest price target for GH Research (NASDAQ:GHRS) was reported by Guggenheim on March 13, 2025. The analyst firm set a price target for $32.00 expecting GHRS to rise to within 12 months (a possible 158.27% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for GH Research (NASDAQ:GHRS) was provided by Guggenheim, and GH Research initiated their buy rating.
There is no last upgrade for GH Research
There is no last downgrade for GH Research.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GH Research, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GH Research was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
While ratings are subjective and will change, the latest GH Research (GHRS) rating was a initiated with a price target of $0.00 to $32.00. The current price GH Research (GHRS) is trading at is $12.39, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.